Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-Direct2: Calorie Restricted Dietary Intervention in Type 2 Diabetes Patients With Obesity
NCT07753447Phase 4Completed
- Sponsor
- The Catholic University of Korea Yeouido St. Mary's Hospital
- Start
- Jul 2025
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) and obesity (2 arms), sponsored by The Catholic University of Korea Yeouido St. Mary's Hospital. Primary endpoint: Remission of Type 2 Diabetes at 12 weeks. Started Jul 2025; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT07753447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07753447.